Manufacturer of Controlled Substances; Applications:

Federal Register: August 4, 2010 (Volume 75, Number 149)

Notices

Page 47029

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr04au10-80

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal

Regulations (CFR), this is notice that on January 27, 2009, Johnson

Matthey Pharma Services, 70 Flagship Drive, North Andover,

Massachusetts 01845, made application to the Drug Enforcement

Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:

Drug

Schedule

Amphetamine (1100)......................... II

Hydrocodone (9193)......................... II

Methylphenidate (1724)..................... II

The company plans to utilize this facility to manufacture small quantities of the listed controlled substances in bulk and to conduct analytical testing in support of the company's primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to the company's customers.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of

Diversion Control, Federal Register Representative (ODL), 8701

Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than October 4, 2010.

Dated: July 23, 2010.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug

Enforcement Administration.

FR Doc. 2010-19078 Filed 8-3-10; 8:45 am

BILLING CODE 4410-09-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT